EP 1148878 A1 20011031 - 1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AS RADIODIGANOSTIC AGENTS AND THEIR USE IN DETERMINING HYPOXIA AND RADIORESISTANCE OF TUMORS
Title (en)
1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AS RADIODIGANOSTIC AGENTS AND THEIR USE IN DETERMINING HYPOXIA AND RADIORESISTANCE OF TUMORS
Title (de)
1,4,8,11-TETRAAZA-CYCLOTETRADECANE DERIVATE ALS RADIODIAGNOSTIKA UND DEREN VERWENDUNG ZUR BESTIMMUNG VON HYPOXIA UND RADIORESISTENZ VON TUMOREN
Title (fr)
DERIVES 1,4,8,11-TETRAAZACYCLOTETRADECANE UTILES EN TANT QU'AGENTS DE RADIODIAGNOSTIC ET UTILISATION DE CES DERNIERS DANS LA DETERMINATION DE L'HYPOXIE ET DE LA RADIORESISTANCE DES TUMEURS
Publication
Application
Priority
- US 0001754 W 20000126
- US 11725399 P 19990126
Abstract (en)
[origin: WO0043004A1] 1,4,8,11-Tetraazacyclotetradecane which is chemically linked to from one to four nitroimidazol groups provides an effective radiodiagnostic agent for determining tissue hypoxia and radioresistance of tumor tissue.
IPC 1-7
IPC 8 full level
A61K 49/00 (2006.01); A61K 51/04 (2006.01); C07B 59/00 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); C07F 13/00 (2006.01)
CPC (source: EP)
A61K 49/0002 (2013.01); A61K 51/0497 (2013.01); C07B 59/002 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07F 13/005 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0043004 A1 20000727; CA 2361115 A1 20000727; EP 1148878 A1 20011031; EP 1148878 A4 20030402
DOCDB simple family (application)
US 0001754 W 20000126; CA 2361115 A 20000126; EP 00908353 A 20000126